Antibiotic Stewardship in Cattle: Welfare, Resistance, and Reform

Antibiotic use in cattle farming is both a welfare tool and a global public health concern. Reducing unnecessary antibiotic use while maintaining animal welfare requires systematic changes to housing, management, and veterinary practice.

Key Facts

Cattle are among the largest users of veterinary antibiotics globally — respiratory disease and mastitis are primary drivers
Approximately 70% of global antibiotic consumption occurs in animal agriculture, according to WHO estimates
Antimicrobial resistance (AMR) driven by agricultural antibiotic use is a leading global public health threat
Prophylactic (preventive) dry cow therapy — treating all cows at drying-off regardless of infection — is a major use category
Selective dry cow therapy treats only infected cows, reducing antibiotic use by 30–50% with careful management
EU regulations effective from 2022 ban prophylactic antibiotic use and restrict the use of antibiotics critically important for human medicine
Better housing, lower stocking densities, and reduced stress improve immune function and reduce antibiotic need
Vaccination programmes can significantly reduce reliance on antibiotics for respiratory disease in feedlot cattle

Welfare Considerations

Antibiotic stewardship in cattle farming sits at the intersection of animal welfare and human public health. Antibiotics are essential welfare tools when cattle develop bacterial infections — withholding treatment to reduce antibiotic use would cause animal suffering. The welfare-compatible path to lower antibiotic use is to address the underlying conditions that necessitate treatment: respiratory disease from crowding and poor ventilation, mastitis from inadequate milking hygiene and housing, and metabolic disease from inappropriate nutrition. Improving these conditions simultaneously improves animal welfare and reduces antibiotic need. Blanket prophylactic treatment — using antibiotics routinely on all animals at certain production stages regardless of need — is the primary target for reduction, as it contributes to resistance without providing welfare benefit beyond targeted treatment. Selective dry cow therapy, supported by good mastitis surveillance and prompt treatment of infected cows, maintains welfare outcomes while substantially reducing overall antibiotic consumption.

What You Can Do

Support retailers and food companies that require antibiotic stewardship commitments from their beef and dairy suppliers
Advocate for veterinary prescription requirements for all agricultural antibiotic use — as now required in the EU
Choose beef and dairy from producers with transparent antibiotic use reporting and verified low-use practices
Support research into vaccination and non-antibiotic disease management alternatives for common cattle conditions
Reduce beef and dairy consumption to lower demand pressure on intensive production systems with high antibiotic use